Scandinavian ChemoTech AB (publ) (FRA:8V6)

Scandinavian ChemoTech AB Revenue

Scandinavian ChemoTech AB had revenue of 3.32M SEK in the quarter ending September 30, 2025, with 121.75% growth. This brings the company's revenue in the last twelve months to 11.68M, up 132.07% year-over-year. In the year 2024, Scandinavian ChemoTech AB had annual revenue of 6.57M with 132.67% growth.

• Revenue (ttm): 11.68M SEK
• Revenue Growth: +132.07%
• P/S Ratio: 7.05
• Revenue / Employee: 1.95M SEK
• Employees: 6
• Market Cap: 7.44M EUR

Revenue Chart

* This company reports financials in SEK.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	6.57M	3.74M	132.67%
Dec 31, 2023	2.82M	2.35M	496.62%
Dec 31, 2022	473.00K	-2.11M	-81.70%
Dec 31, 2021	2.59M	1.17M	82.81%
Dec 31, 2020	1.41M	-3.24M	-69.63%